{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T14:13:49Z","timestamp":1688998429685},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1007\/s11936-000-0014-1","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T06:14:18Z","timestamp":1180851258000},"page":"205-212","source":"Crossref","is-referenced-by-count":4,"title":["Thromboangiitis Obliterans (Buerger\u2019s Disease)"],"prefix":"10.1007","volume":"2","author":[{"given":"Michael R.","family":"Jaff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"14_CR1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0889-857X(21)01058-9","volume":"16","author":"JT Lie","year":"1990","unstructured":"Lie JT: Diagnostic histopathology of major systemic and pulmonary vasculitic syndromes. Rheum Clin North Am 1990, 16:269\u2013292.","journal-title":"Rheum Clin North Am"},{"key":"14_CR2","first-page":"202","volume":"23","author":"F Winiwarter Von","year":"1879","unstructured":"Von Winiwarter F: Ueber eine eigenthumliche form von endarteritis und endophlebitis mit gangran des fusses. Arch Klin Chir 1879, 23:202\u2013226.","journal-title":"Arch Klin Chir"},{"key":"14_CR3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00000441-190810000-00011","volume":"136","author":"L Buerger","year":"1908","unstructured":"Buerger L: Thromboangiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene. Am J Med Sci 1908, 136:567\u2013580.","journal-title":"Am J Med Sci"},{"key":"14_CR4","first-page":"153","volume":"39","author":"JT Lie","year":"1989","unstructured":"Lie JT: The rise and fall and resurgence of thromboangiitis obliterans (Buerger\u2019s disease). Acta Pathol Jpn 1989, 39:153\u2013158.","journal-title":"Acta Pathol Jpn"},{"key":"14_CR5","first-page":"350","volume-title":"Vascular Surgery","author":"JW Olin","year":"2000","unstructured":"Olin JW: Thromboangiitis obliterans (Buerger\u2019s disease). In Vascular Surgery. Edited by Rutherford RB. Philadelphia: W.B. Saunders Co.; 2000:350\u2013364. An outstanding review of TAO with the latest in diagnostic and therapeutic options."},{"key":"14_CR6","first-page":"223","volume":"4","author":"M Jaff","year":"1994","unstructured":"Jaff M, Olin JW, Young JR: Failure of acute-phase reactants to predict disease activity in Takayasu\u2019s arteritis. J Vasc Med Biol 1994, 4:223\u2013227.","journal-title":"J Vasc Med Biol"},{"issue":"suppl 4","key":"14_CR7","first-page":"IV3","volume":"82","author":"JW Olin","year":"1990","unstructured":"Olin JW, Young JR, Graor RA, et al.: The changing clinical spectrum of thromboangiitis obliterans (Buerger\u2019s disease). Circulation 1990, 82(suppl 4):IV3-IV8. Important information on the increase in incidence of TAO in women, importance of tobacco cessation, and poor outcome for patients with TAO.","journal-title":"Circulation"},{"key":"14_CR8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0021-8707(38)90302-8","volume":"9","author":"FN Westcott","year":"1938","unstructured":"Westcott FN, Wright IS: Tobacco allergy and thromboangiitis obliterans. J Allergy 1938, 9:555\u2013564.","journal-title":"J Allergy"},{"key":"14_CR9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0741-5214(91)90154-M","volume":"14","author":"M Matsushita","year":"1991","unstructured":"Matsushita M, Shionoya S, Matsumoto T: Urinary cotinine measurements in patients with Buerger\u2019s disease: effects of active and passive smoking on the disease process. J Vasc Surg 1991, 14:53\u201358.","journal-title":"J Vasc Surg"},{"key":"14_CR10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0049-3848(92)90282-F","volume":"66","author":"NA Chaudhury","year":"1992","unstructured":"Chaudhury NA, Pietraszek MH, Hachiya T, et al.: Plasminogen activators and plasminogen activator inhibitor I before and after venous occlusion of the upper limb in thromboangiitis obliterans (Buerger\u2019s disease). Thromb Res 1992, 66:321\u2013329.","journal-title":"Thromb Res"},{"key":"14_CR11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/ard.52.3.247-b","volume":"52","author":"M Casellas","year":"1993","unstructured":"Casellas M, Perez A, Cabero L: Buerger\u2019s disease and antiphospholipid antibodies in pregnancy. Ann Rheum Dis 1993, 52:247\u2013248.","journal-title":"Ann Rheum Dis"},{"key":"14_CR12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s100670050055","volume":"18","author":"D Biasi","year":"1999","unstructured":"Biasi D, Caramaschi P, Carletto A, et al.: A case of Buerger\u2019s disease associated with high levels of lipoprotein(a). Clin Rheumatol 1999, 18:59\u201360.","journal-title":"Clin Rheumatol"},{"key":"14_CR13","first-page":"17","volume":"315","author":"J Eichhorn","year":"1998","unstructured":"Eichhorn J, Sima D, Lindschau C, et al.: Antiendothelial cell antibodies in thromboangiitis obliterans. Am J Med Sci 1998, 315:17\u201323. Potentially very important original data that may have identified a diagnostic marker for TAO that did not previously exist.","journal-title":"Am J Med Sci"},{"issue":"suppl 2","key":"14_CR14","first-page":"II211","volume":"94","author":"S Makita","year":"1996","unstructured":"Makita S, Nakamura M, Murakami H, et al.: Impaired endothelium-dependent vasorelaxation in peripheral vasculature of patients with thromboangiitis obliterans (Buerger\u2019s disease). Circulation 1996, 94(suppl 2):II211-II215.","journal-title":"Circulation"},{"key":"14_CR15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0002-9610(99)00046-X","volume":"177","author":"S Sasaki","year":"1999","unstructured":"Sasaki S, Sakuma M, Kunihara T, et al.: Current trends in thromboangiitis obliterans (Buerger\u2019s disease) in women. Am J Surg 1999, 177:316\u2013320.","journal-title":"Am J Surg"},{"key":"14_CR16","first-page":"207","volume-title":"Vascular Surgery","author":"S Shinoya","year":"1989","unstructured":"Shinoya S: Buerger\u2019s disease (thromboangiitis obliterans). In Vascular Surgery. Edited by Rutherford RB. Philadelphia: W.B. Saunders Co.; 1989:207\u2013217."},{"key":"14_CR17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00000441-192908000-00009","volume":"178","author":"EV Allen","year":"1929","unstructured":"Allen EV: Thromboangiitis obliterans: methods of diagnosis of chronic occlusive arterial lesions distal to the wrist with illustrative cases. Am J Med Sci 1929, 178:237\u2013244.","journal-title":"Am J Med Sci"},{"key":"14_CR18","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0022-5223(97)70243-5","volume":"113","author":"F Donatelli","year":"1997","unstructured":"Donatelli F, Triggiani M, Nascimbene S, et al.: Thromboangiitis obliterans of coronary and internal thoracic arteries in a young woman. J Thorac Cardiovasc Surg 1997, 113:800\u2013802.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"14_CR19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/000331979804900611","volume":"49","author":"Garcia A Nunex","year":"1998","unstructured":"Nunex Garcia A, Lopez Cubero L, Rico Zalba L, et al.: Thromboangiitis obliterans (Buerger\u2019s disease) with intestinal involvement. Angiology 1998, 49:489\u2013492.","journal-title":"Angiology"},{"key":"14_CR20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/01.STR.30.3.687","volume":"30","author":"AJ Larner","year":"1999","unstructured":"Larner AJ, Kidd D, Elkington P, et al.: Spatz-Lindenberg disease. A rare cause of vascular dementia. Stroke 1999, 30:687\u2013689.","journal-title":"Stroke"},{"key":"14_CR21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1078-5884(96)80081-5","volume":"11","author":"MZ Papa","year":"1996","unstructured":"Papa MZ, Rabi I, Adar R: A point scoring system for the clinical diagnosis of Buerger\u2019s disease. Eur J Vasc Endovasc Surg 1996, 11:335\u2013359. Important point-scoring system that highlights the clinical, angiographic, and histopathologic criteria for the diagnosis of TAO.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"14_CR22","first-page":"L28","volume":"14","author":"F Corelli","year":"1973","unstructured":"Corelli F: Buerger\u2019s disease: cigarette smoker disease may always be cured by medical therapy alone\u2014uselessness of operative treatment. J Cardiovasc Surg 1973, 14:L28-L36.","journal-title":"J Cardiovasc Surg"},{"key":"14_CR23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4065\/73.6.529","volume":"73","author":"WM Hooten","year":"1998","unstructured":"Hooten WM, Bruns HK, Hays JT: Inpatient treatment of severe nicotine dependence in a patient with thromboangiitis obliterans (Buerger\u2019s disease). Mayo Clin Proc 1998, 73:529\u2013532.","journal-title":"Mayo Clin Proc"},{"key":"14_CR24","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0140-6736(90)90346-7","volume":"335","author":"JN Fiessinger","year":"1990","unstructured":"Fiessinger JN, Schafer M: Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. Lancet 1990, 335:555\u2013557. Novel parenteral therapy that demonstrates promise in healing of ischemic ulcers and resolution of rest pain.","journal-title":"Lancet"},{"key":"14_CR25","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S1078-5884(98)80032-4","volume":"15","author":"The European TAO Study Group","year":"1998","unstructured":"The European TAO Study Group: Oral iloprost in the treatment of thromboangiitis obliterans (Buerger\u2019s disease): a double-blind, randomized, placebo-controlled trial. Eur J Vasc Endovasc Surg 1998, 15:300\u2013307.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"14_CR26","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0741-5214(99)70221-1","volume":"29","author":"JJ Swigris","year":"1999","unstructured":"Swigris JJ, Olin JW, Mekhail NA: Implantable spinal cord stimulator to treat the ischemic manifestations of thromboangiitis obliterans (Buerger\u2019s disease). J Vasc Surg 1999, 29:928\u2013935.","journal-title":"J Vasc Surg"},{"key":"14_CR27","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0741-5214(98)70022-9","volume":"28","author":"JM Isner","year":"1998","unstructured":"Isner JM, Baumgartner I, Rauh G, et al.: Treatment of thromboangiitis obliterans (Buerger\u2019s disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J Vasc Surg 1998, 28:964\u2013975. Very important emerging information about a potentially highly effective therapy for end-stage TAO.","journal-title":"J Vasc Surg"},{"key":"14_CR28","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archsurg.1974.01350290029003","volume":"108","author":"K Inada","year":"1974","unstructured":"Inada K, Iwashima Y, Okada A, Matsumoto K: Non-atherosclerotic segmental arterial occlusion of the extremities. Arch Surg 1974, 108:663\u2013667.","journal-title":"Arch Surg"},{"key":"14_CR29","first-page":"54","volume":"78","author":"EA Hussein","year":"1993","unstructured":"Hussein EA, el Dorri A: Intra-arterial streptokinase as adjuvant therapy for complicated Buerger\u2019s disease\u2014early trials. Int Surg 1993, 78:54\u201358.","journal-title":"Int Surg"},{"key":"14_CR30","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJM199809033391005","volume":"339","author":"JR Sims","year":"1998","unstructured":"Sims JR, Hanson EL: Images in clinical medicine. Thromboangiitis obliterans (Buerger\u2019s disease). N Engl J Med 1998, 339:672. Although this is a single case report, the images are classic for TAO. This adjuvant therapy may hold promise for the treatment of patients with TAO.","journal-title":"N Engl J Med"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-000-0014-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-000-0014-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-000-0014-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T14:20:46Z","timestamp":1628950846000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-000-0014-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["14"],"URL":"https:\/\/doi.org\/10.1007\/s11936-000-0014-1","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}